Sarah A. Teichmann serves as Executive at 10x Genomics, Inc., where they oversee executive responsibilities. Since joining the company, Sarah A. Teichmann has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Aug 30, 2024 involved receiving (via award) 19,002 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Aug 30, 2024 | TXG | $0 | Award | 19,002 | $N/A | Discretionary |
Sarah A. Teichmann currently holds 19,002 shares of 10x Genomics, Inc. (TXG), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Sarah A. Teichmann has been a net neutral trader of TXG stock. They have purchased $0 and sold $0 worth of shares.
Sarah A. Teichmann's most recent insider trade was on Aug 30, 2024, when they sold 19,002 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted